<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>药通社 | wechat-feeds</title><link>http://MzU5NjUwOTgyNg.favicon.privacyhide.com/favicon.ico</link><description>药通社：政策、资讯、产业、技术</description><managingEditor> (hellodword)</managingEditor><pubDate>Tue, 15 Jun 2021 23:21:16 +0800</pubDate><image><url>http://MzU5NjUwOTgyNg.favicon.privacyhide.com/favicon.ico</url><title>药通社 | wechat-feeds</title><link>http://MzU5NjUwOTgyNg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>转发赠票｜生物医药创新国际化领跑者论坛开启在即，领略数十位创新药掌门人迈向全球化风向标</title><link>https://mp.weixin.qq.com/s/-VDroRWw_SJcr74-8cPkZA</link><description></description><content:encoded><![CDATA[转发赠票｜生物医药创新国际化领跑者论坛开启在即，领略数十位创新药掌门人迈向全球化风向标]]></content:encoded><pubDate>Tue, 15 Jun 2021 21:54:55 +0800</pubDate></item><item><title>CDE：不同规格申报、变更等技术问题，这样操作！</title><link>https://mp.weixin.qq.com/s/ZRz_riYKlGMXnaQMx6_zRg</link><description></description><content:encoded><![CDATA[CDE：不同规格申报、变更等技术问题，这样操作！]]></content:encoded><pubDate>Tue, 15 Jun 2021 21:54:55 +0800</pubDate></item><item><title>峰会副主席程泽能教授：制剂创新助力改良型新药企业弯道超车</title><link>https://mp.weixin.qq.com/s/8F9hq8ya4V-Lm8NvCoIuTQ</link><description></description><content:encoded><![CDATA[峰会副主席程泽能教授：制剂创新助力改良型新药企业弯道超车]]></content:encoded><pubDate>Tue, 15 Jun 2021 21:54:55 +0800</pubDate></item><item><title>药典委：关于泮托拉唑钠肠溶片国家药品标准草案的公示</title><link>https://mp.weixin.qq.com/s/9s18DyF2n668fiDLt2rBvw</link><description></description><content:encoded><![CDATA[药典委：关于泮托拉唑钠肠溶片国家药品标准草案的公示]]></content:encoded><pubDate>Tue, 15 Jun 2021 21:54:55 +0800</pubDate></item><item><title>宝，我报名参会了，什么会，8月苏州CMC-China与你来相会</title><link>https://mp.weixin.qq.com/s/prLOB9gclB6lou9Fmhh2_w</link><description></description><content:encoded><![CDATA[宝，我报名参会了，什么会，8月苏州CMC-China与你来相会]]></content:encoded><pubDate>Tue, 15 Jun 2021 21:54:55 +0800</pubDate></item><item><title>2021ASCO重磅登场，亚盛、百济、君实……，国内创新药企谁领风骚？</title><link>https://mp.weixin.qq.com/s/1GG2eyEBNQUpHn00RCEFlw</link><description></description><content:encoded><![CDATA[2021ASCO重磅登场，亚盛、百济、君实……，国内创新药企谁领风骚？]]></content:encoded><pubDate>Tue, 15 Jun 2021 21:54:55 +0800</pubDate></item><item><title>一大波医药类职位，了解下哦！</title><link>https://mp.weixin.qq.com/s/vyzLlBamAfZVFaACuJnZAg</link><description></description><content:encoded><![CDATA[一大波医药类职位，了解下哦！]]></content:encoded><pubDate>Tue, 15 Jun 2021 21:54:55 +0800</pubDate></item><item><title>机遇与挑战并存：中国高端制剂+改良新药峰会即将开幕</title><link>https://mp.weixin.qq.com/s/x0jSMVtacl6h_1U7pvOA9A</link><description></description><content:encoded><![CDATA[机遇与挑战并存：中国高端制剂+改良新药峰会即将开幕]]></content:encoded><pubDate>Tue, 15 Jun 2021 21:54:55 +0800</pubDate></item><item><title>​仿制药BE结果是否确为临床等效的金标准？</title><link>https://mp.weixin.qq.com/s/yhn_qFMtIybQtFacgIA0YA</link><description></description><content:encoded><![CDATA[​仿制药BE结果是否确为临床等效的金标准？]]></content:encoded><pubDate>Mon, 14 Jun 2021 19:30:07 +0800</pubDate></item><item><title>江苏威凯尔1类新药，JAK1抑制剂VC005临床申请获受理</title><link>https://mp.weixin.qq.com/s/WAhttjF4V9n-xArNPqmL_w</link><description></description><content:encoded><![CDATA[江苏威凯尔1类新药，JAK1抑制剂VC005临床申请获受理]]></content:encoded><pubDate>Mon, 14 Jun 2021 19:30:07 +0800</pubDate></item><item><title>嘉宾发布！2021中国（苏州）抗体药物、细胞和基因治疗峰会邀您共赴行业盛会！</title><link>https://mp.weixin.qq.com/s/W_43Tuai1_UuCBBpqfPr0w</link><description></description><content:encoded><![CDATA[嘉宾发布！2021中国（苏州）抗体药物、细胞和基因治疗峰会邀您共赴行业盛会！]]></content:encoded><pubDate>Mon, 14 Jun 2021 19:30:07 +0800</pubDate></item><item><title>Hi，医药人！这个八月跟着药融圈全面玩转CMC-China吧</title><link>https://mp.weixin.qq.com/s/ir8fReiOB3m_Cnk_RgOzBQ</link><description></description><content:encoded><![CDATA[Hi，医药人！这个八月跟着药融圈全面玩转CMC-China吧]]></content:encoded><pubDate>Mon, 14 Jun 2021 19:30:07 +0800</pubDate></item><item><title>制药人才网！了解下哦！</title><link>https://mp.weixin.qq.com/s/bsPipiIfpgOCU6fQjcirYg</link><description></description><content:encoded><![CDATA[制药人才网！了解下哦！]]></content:encoded><pubDate>Mon, 14 Jun 2021 19:30:07 +0800</pubDate></item><item><title>恒瑞：连续3年入选全球制药企业50强！2021还有4家中国药企入选！</title><link>https://mp.weixin.qq.com/s/rIbif_9e5ZBXQVtKvWwLAg</link><description></description><content:encoded><![CDATA[恒瑞：连续3年入选全球制药企业50强！2021还有4家中国药企入选！]]></content:encoded><pubDate>Sun, 13 Jun 2021 22:28:02 +0800</pubDate></item><item><title>大手笔！泰格医药：98亿参与设立生命健康产业基金！</title><link>https://mp.weixin.qq.com/s/njnnP2AaT0a3xDyF90ycvg</link><description></description><content:encoded><![CDATA[大手笔！泰格医药：98亿参与设立生命健康产业基金！]]></content:encoded><pubDate>Sun, 13 Jun 2021 22:28:02 +0800</pubDate></item><item><title>Hi，医药人！这个八月跟着药融圈全面玩转CMC-China吧</title><link>https://mp.weixin.qq.com/s/RTFeU3whtRmwHg_LkPY9vQ</link><description></description><content:encoded><![CDATA[Hi，医药人！这个八月跟着药融圈全面玩转CMC-China吧]]></content:encoded><pubDate>Sun, 13 Jun 2021 22:28:02 +0800</pubDate></item><item><title>制药人才网！了解下哦！</title><link>https://mp.weixin.qq.com/s/PFcK-pgMGDPf1ZHB_m_R1g</link><description></description><content:encoded><![CDATA[制药人才网！了解下哦！]]></content:encoded><pubDate>Sun, 13 Jun 2021 22:28:02 +0800</pubDate></item><item><title>合集 | 靶点社往期精彩文章！</title><link>https://mp.weixin.qq.com/s/U2JBwyX3LqOBNtnOr3svnQ</link><description></description><content:encoded><![CDATA[合集 | 靶点社往期精彩文章！]]></content:encoded><pubDate>Sun, 13 Jun 2021 22:28:02 +0800</pubDate></item><item><title>5月份，FDA 批准上市新药汇总</title><link>https://mp.weixin.qq.com/s/afzJ1ZK5GstkpOSUM3waww</link><description></description><content:encoded><![CDATA[5月份，FDA 批准上市新药汇总]]></content:encoded><pubDate>Sat, 12 Jun 2021 22:04:32 +0800</pubDate></item><item><title>Hi，医药人！这个八月跟着药融圈全面玩转CMC-China吧</title><link>https://mp.weixin.qq.com/s/OtkHy09MvZ23GIS1T_Rg5g</link><description></description><content:encoded><![CDATA[Hi，医药人！这个八月跟着药融圈全面玩转CMC-China吧]]></content:encoded><pubDate>Sat, 12 Jun 2021 22:04:32 +0800</pubDate></item></channel></rss>